Overview of Dr. Schoenfeld
Dr. Adam Schoenfeld is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from University of California (San Francisco) School of Medicine and has been in practice 3 years. He is one of 469 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 60 publications and over 500 citings.
Office
Memorial Sloan Kettering Cancer Center Commack
650 Commack Road
New York, NY 10021- Is this information wrong?
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 2014 - 2017
- University of California San Francisco School of MedicineClass of 2014, AOA
Certifications & Licensure
- CA State Medical License 2016 - Present
- FL State Medical License 2021 - Present
- NJ State Medical License 2020 - 2025
- NY State Medical License 2017 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Kaiser Permanente Medical Student Scholarship Award Kaiser Permanente, 2013
- New England Journal of Medicine Scholar New England Journal of Medicine, 2012
- Phi Beta Kappa Society Member Dartmouth College, 2009
Publications & Presentations
PubMed
- 38 citationsAcquired MET Exon 14 Alteration Drives Secondary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in EGFR-Mutated Lung Cancer.Ken Suzawa, Michael Offin, Adam J. Schoenfeld, Andrew J. Plodkowski, Igor Odintsov
JCO Precision Oncology. 2019-05-10 - 29 citationsMolecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung Cancers.Noura J Choudhury, Antonio Marra, Jane S Y Sui, Jessica Flynn, Soo-Ryum Yang
Journal of Thoracic Oncology. 2023-04-01 - 60 citationsAcquired BRAF Rearrangements Induce Secondary Resistance to EGFR therapy in EGFR-Mutated Lung Cancers.Morana Vojnic, Daisuke Kubota, Christopher Kurzatkowski, Michael Offin, Ken Suzawa
Journal of Thoracic Oncology. 2019-05-01
Journal Articles
- Effect of Osimertinib and Bevacizumab on Progression-Free Survival for Patients with Metastatic EGFR-Mutant Lung CancersHelena A Yu, Adam J Schoenfeld, Jamie E Chaft, Gregory J Riely, JAMA Oncology
- Synthesis, Structure, Dynamics, and Selective Methylation of Platinum and Palladium Diphosphametallacyclobutane ComplexesChapp TW, Schoenfeld A, Sanderson MD, Chang C, Glueck DS, Golen J, Moore C, Rheingold A, Organometallics, 2012
- Effects of Linker Length on the Rate and Selectivity of Platinum-Catalyzed Asymmetric Alkylation of the Bis(isitylphosphino)alkanes IsHP(CH2)nPHIs (is = 2,4,6-(i-pr)3C...Chapp TW, Schoenfeld A, Glueck DS, Organometallics, 2010
Press Mentions
- Study Finds Growing Reason to Be Wary of Some Reflux DrugsJanuary 29th, 2016
- Popular Acid Reflux Drugs Are Linked to Kidney Disease RiskJanuary 11th, 2016
Professional Memberships
- Member
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: